Radiologic Monitoring of Hepatocellular Carcinoma Tumor Viability after Transhepatic Arterial Chemoembolization: Estimating the Accuracy of Contrast-enhanced Cross-sectional Imaging with Histopathologic Correlation

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 1, 2009, Pages 30-38

  Hunt, Stephen J ^a   Yu, Woojin ^b   Weintraub, Joshua ^c   Prince, Martin R ^d   Kothary, Nishita ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Columbia University Irving Medical Center   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; GADOLINIUM; IODINATED CONTRAST MEDIUM; MITOMYCIN C;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 57849151493     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.09.034     Document Type: Article

References (45)

1. Camma C., Schepis F., Orlando A., et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224 (2002) 47-54
2. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
3. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
4. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
5. Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation 80 suppl (2005) S113-S119
6. Llovet J.M. Expanding HCC criteria for liver transplant: the urgent need for prospective, robust data. Liver Transpl 12 (2006) 1741-1743
7. Filmus J., and Capurro M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn 8 (2004) 207-212
8. Tanaka K., Inoue S., Numata K., et al. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization. AJR Am J Roentgenol 158 (1992) 541-546
9. Catalano O., Esposito M., Lobianco R., Cusati B., Altei F., and Siani A. Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced doppler ultrasonography. Cardiovasc Intervent Radiol 22 (1999) 486-492
10. Hosoki T., Yosioka Y., Matsubara T., et al. Power Doppler sonography of hepatocellular carcinoma treated by transcatheter arterial chemoembolization. Assessment of the therapeutic effect. Acta Radiol 40 (1999) 639-643
11. Kubota K., Hisa N., Nishikawa T., et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 26 (2001) 184-190
12. Yoshioka H., Nakagawa K., Shindou H., et al. MR imaging of the liver before and after transcatheter hepatic chemo-embolization for hepatocellular carcinoma. Acta Radiol 31 (1990) 63-67
13. Murakami T., Nakamura H., Hori S., et al. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA. Acta Radiol 34 (1993) 399-403
14. Yamashita Y., Yoshimatsu S., Sumi M., Harada M., and Takahashi M. Dynamic MR imaging of hepatoma treated by transcatheter arterial embolization therapy: assessment of treatment effect. Acta Radiol 34 (1993) 303-308
15. Winter III T.C., Takayasu K., Muramatsu Y., et al. Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 192 (1994) 379-387
16. Ito K., Honjo K., Fujita T., et al. Therapeutic accuracy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology. J Comput Assist Tomogr 19 (1995) 198-203
17. Kim T., Murakami T., Oi H., et al. Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr 19 (1995) 948-954
18. Castrucci M., Sironi S., De Cobelli F., Salvioni M., and Del Maschio A. Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization. Abdom Imaging 21 (1996) 488-494
19. Yan F.H., Zhou K.R., Cheng J.M., et al. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World J Gastroenterol 8 (2002) 658-662
20. Kuo Y.T., Li C.W., Chen C.Y., Jao J., Wu D.K., and Liu G.C. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19 (2004) 598-604
21. Zhao J.G., Feng G.S., Kong X.Q., Li X., Li M.H., and Cheng Y.S. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging. World J Gastroenterol 10 (2004) 1152-1156
22. Kamel I.R., Bluemke D.A., Eng J., et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 17 (2006) 505-512
23. Takayasu K., Moriyama N., Muramatsu Y., et al. Hepatic arterial embolization for hepatocellular carcinoma: comparison of CT scans and resected specimens. Radiology 150 (1984) 661-665
24. Murayama S., Tsukamoto Y., Watanabe H., and Nakata H. Computed tomography of residual hepatomas following transcatheter arterial embolization. J Comput Assist Tomogr 10 (1986) 969-972
25. Muramatsu Y., Takayasu K., Moriyama N., et al. Peripheral low-density area of hepatic tumors: CT-pathologic correlation. Radiology 160 (1986) 49-52
26. Jinno K., Moriwaki S., Tanada M., Wada T., Mandai K., and Okada Y. Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 31 suppl (1992) S7-S12
27. Choi B.I., Kim H.C., Han J.K., et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182 (1992) 709-713
28. Imaeda T., Yamawaki Y., Seki M., et al. Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol 16 (1993) 209-213
29. Nishimine K., Uchida H., Matsuo N., et al. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 33 suppl (1994) S60-S68
30. Hori M., Murakami T., Kim T., et al. Sensitivity of double-phase helical CT during arterial portography for detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 22 (1998) 861-867
31. Takayasu K., Arii S., Matsuo N., et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 175 (2000) 699-704
32. Vogl T.J., Trapp M., Schroeder H., et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214 (2000) 349-357
33. Kim H.C., Kim A.Y., Han J.K., et al. Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images. Radiology 225 (2002) 773-780
34. Ebied O.M., Federle M.P., Carr B.I., et al. Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer 97 (2003) 1042-1050
35. Guan Y.S., Zheng X.H., Zhou X.P., et al. Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Gastroenterol 10 (2004) 2127-2129
36. Jang M.K., Lee H.C., Kim I.S., et al. Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization. J Gastroenterol Hepatol 19 (2004) 1074-1080
37. Chung Y.H. A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Intervirology 48 (2005) 46-51
38. Jang K.M., Choi D., Lim H.K., et al. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of the previous serial CT images. Korean J Radiol 6 (2005) 153-160
39. Kim S.H., Lee W.J., Lim H.K., and Lim J.H. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography. J Comput Assist Tomogr 31 (2007) 198-203
40. Tanaka K., Numata K., Okazaki H., Nakamura S., Inoue S., and Takamura Y. Diagnosis of portal vein thrombosis in patients with hepatocellular carcinoma: accuracy of color Doppler sonography compared with angiography. AJR Am J Roentgenol 160 (1993) 1279-1283
41. Cioni D., Lencioni R., and Bartolozzi C. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound. Eur Radiol 10 (2000) 1570-1575
42. Rubin J.M., Bude R.O., Carson P.L., Bree R.L., and Adler R.S. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology 190 (1994) 853-856
43. Oi H., Murakami T., Kim T., Matsushita M., Kishimoto H., and Nakamura H. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. AJR Am J Roentgenol 166 (1996) 369-374
44. Yu J.S., Kim K.W., Sung K.B., Lee J.T., and Yoo H.S. Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology 203 (1997) 737-742
45. Kim M.J., Mitchell D.G., Ito K., and Kim P.N. Hepatic MR imaging: comparison of 2D and 3D gradient echo techniques. Abdom Imaging 26 (2001) 269-276